Tecnologia mHealth e obesidade: redesign e validação do LISA Obesidade

Objetivo: O objetivo do presente estudo é o redesign e a validação do aplicativo LISA Obesidade, desenvolvido de acordo com os fundamentos do letramento em saúde. Metodologia: Trata-se de um estudo metodológico, relacionado ao redesing e validação de artefato tecnológico direcionado à prevenção e controle da obesidade. Após o redesign, realizado por equipe multiprofissional, o…

How Far Can Conversational Agents Contribute to IBD Patient Health Care—A Review of the Literature

Modern societies are facing health and healthcare challenges as never seen before. The digital world in which we are living today considers digital health interventions such as “internet-delivered” therapy (e-Therapy) or mobile apps as an integrated part of healthcare systems. Digital transformation in health care requires the active involvement of patients as the central part…

Persistently positive SARS-CoV-2-specific IgM during 1-year follow-up

Dear Editor, Immunoglobulin M (IgM) antibodies typically appear in the early stageof infection and have a short maintenance time, so IgM is frequentlyused as a diagnostic criterion for acute or recent disease.1However,unconventional IgM‐specific responses have been described in SARS‐CoV‐2 infection, raising doubts about the use of IgM as a biomarkerfor COVID‐19 and the role of this antibody in immunity to SARS‐CoV‐2

Avanços e desafios da comunicação digital em saúde na era da pandemia

Introdução: a pandemia do COVID-19 provocou mudanças importantes no uso das tecnologias e da comunicação digital. É necessário compreendermos melhor as práticas de enfrentamento da pandemia pela população através da apropriação de informações veiculadas pelas mídias sociais. Espera-se que este trabalho auxilie na formulação de estratégias de educação em saúde na ESF. O objetivo deste…

Dynamics of antibody response to CoronaVac vaccine

Abstract: CoronaVac was the first vaccine approved in Brazil for use in healthcare workers (HCWs). However, there is limited information about it, with little long-term evidence on post-vaccination antibody persistence. This study evaluated the antibody response to SARS-CoV-2 in 1237 HCWs after the first (1D), second dose (2D), and 6 months postvaccination (6mA2D) with CoronaVac. The seropositivity was 88% at 1D, increasing to 99.8% at 2D, but decreasing to 97.9% at 6mA2D, which was also observed at the analyzed antibody levels. Interestingly, the levels in females were higher than males, and we found a positive correlation with previous SARS-CoV-2 infection. Participants with comorbidities had lower levels suggesting the need to monitor for a potential booster dose. Our findings suggest that CoronaVac induced a robust antibody response that wanes significantly over time. Further longitudinal studies are needed to identify whether the antibodies will decline or plateau at a lower level.

Os caminhos da ciência para enfrentar fake news sobre covid-19

Resumo Paralelamente à pandemia de covid-19, a Organização Mundial da Saúde alerta para uma infodemia de fake news relacionadas à doença. Objetiva-se, neste trabalho, conhecer a dimensão do fenômeno e alguns caminhos já identificados pela ciência para enfrentá-lo. Trata-se de uma revisão integrativa da literatura, realizada nas bases Scopus/Elsevier e Medline/PubMed, que incluiu 23 artigos.…